Gastrointestinal Associates of Northeast Tennessee

Johnson City, Tennessee 44060

2 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Inflammatory Bowel Diseases, Moderately to Severely Active Ulcerative Colitis, Nonalcoholic Steatohepatitis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis

Studies at this site

• A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis — Recruiting now
• A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease — Recruiting now
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC — Completed
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed